Company / Operating Cash Flow
Phathom Pharmaceuticals, Inc. Operating Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$166.8M
FY2025
5-year range
-$166.8M / -$137.6M
FY2021-FY2025
Trend
-21.2%
vs FY2024
Sector context
#156 of 216
Health Care
What the data says
At -$167M, Phathom Pharmaceuticals, Inc.'s operating cash flow ranks #156 of 216 in the Health Care sector. Declined from -$138M to -$167M over the past 2 years.
Based on SEC 10-K filings.
-$167M in FY2025.
Declined from -$138M to -$167M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#156 of 216 in Health CareTop 72% of 216This company -$166.8M Sector average $659.0M
▼
-125.3% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow decreased 21.2% year-over-year.
- Ranks #156 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$166.8M | -21.2% |
| FY2024 | -$137.6M | +0.0% |
| FY2023 | -$137.6M | +6.1% |
| FY2022 | -$146.5M | +1.3% |
| FY2021 | -$148.5M | -113.0% |
| FY2020 | -$69.7M | -90.9% |
| FY2019 | -$36.5M | -3468.9% |
| FY2018 | -$1.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026